Ordinary Index Rebalancing in the Solactive Transatlantic Healthcare Equity Index | October 2019

In the ordinary rebalance the following composition will be implemented:

ABBOTT LABORATORIES
BAXTER INTL.
BECTON DICKINSON AND CO
BIOGEN INC
BRISTOL-MYERS SQUIBB CO
CELGENE CORP
CHEMED CORP
CHINA BIOLOGIC PRODUCTS HOLD
COLOPLAST AS CLASS B
CONMED CORP
COOPER COMPANIES INC
DANAHER CORP
DENTSPLY SIRONA INC
ELI LILLY & CO
ESSILORLUXOTTICA
FRESENIUS MEDICAL CARE AG & CO KGAA
GILEAD SCIENCES INC
GLAXOSMITHKLINE PLC
GRIFOLS SA CLASS A
HILL-ROM HOLDINGS INC
HOLOGIC INC
IQVIA HOLDINGS INC
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
LONZA GROUP AG
MEDTRONIC PLC
MERCK & CO. INC.
MERCK KGAA
NOVARTIS AG
NOVO NORDISK AS CLASS B
ORION OYJ CLASS B
PFIZER INC
QIAGEN NV
QUEST DIAGNOSTICS INC
RECORDATI SPA
RESMED INC
ROCHE HOLDING AG
SANOFI SA
SIEMENS HEALTHINEERS AG
SMITH & NEPHEW PLC
SONOVA HOLDING AG
SPARK THERAPEUTICS INC
STERIS PLC
STRAUMANN HOLDING AG
STRYKER CORP
THERMO FISHER SCIENTIFIC INC
UCB SA
WELLCARE HEALTH PLANS
ZIMMER BIOMET HOLDINGS INC
ZOETIS INC